Focus: Infection Control

FDA says healthcare facilities should use safer scopes

Agency suggests companies make disposable versions


The Food and Drug Administration (FDA) said companies that make duodenoscopes should begin making disposable versions, according to an article on The New York Times website.

The agency also said that hospitals should start to transition to models with disposable components to reduce the risk of infection.

FDA tests revealed that one in 20 harbored disease-causing microbes like E. coli even after being properly cleaned.

Medical experts have urged the FDA to force manufacturers to make the scopes safer and easier to decontaminate — or to take them off the market.

Read the article.



September 6, 2019


Topic Area: Infection Control


Recent Posts

Technological Readiness: The Missing Construction Milestone

A new building can be complete by most measures but still not be technologically or operationally ready.


From Cooling Towers to Cost Savings: Hospital Seizes Power-Saving Opportunity

Case study: Arkansas hospital increases energy efficiency by diagnosing cooling tower issues and treating its entire mechanical system.


Community Health Center of Buffalo Reports Data Breach

CHCB is working to review its existing data privacy policies and procedures.


CRAB Alert: The EVS Role in Preventing Infection

CRAB is a Gram-negative bacterium that causes bloodstream infections, ventilator-associated pneumonia, surgical wound infections and meningitis in hospitalized patients.


Why Hospital Waiting Rooms Aren't Going Away

Despite advances in technology, thoughtfully designed reception spaces continue to evolve.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.